According to previous research, SLC2A1 appears to serve as an oncogene in a variety of malignancies, including lung cancer [31, 53, 54], pancreatic cancer [28], oral cancer [55], and so on. The gene discussed is SLC2A1; the disease is pancreatic neoplasm.